Pfizer: Phase 3 Study Postitive Results of Weekly Prophylaxis

Once-Weekly Prophylaxis Treatment with BeneFIX® Significantly Reduced Annualized Bleeding Rate Compared to On-Demand Treatment_____________________________Pfizer Inc. announced the positive results of a Phase 3 study comparing a prophylaxis regimen of BeneFIX® Coagulation Factor IX (Recombinant) 100 IU/kg once-weekly to on-demand treatment in people with moderately severe to severe hemophilia B. The top-line results of the study showed […]

USDA's Summer Meal Program

The financial strain of dealing with a bleeding disorder can be felt on many levels.  It is not always easy to pay the medical bills and make ends meet.  Summer time can be even harder for some families who are trying to eat healthy but are having a hard time putting food on the table.During […]

Penn Research Could Improve Hemophilia Treatment

*This article was originally posted on July 17, 2014 in Penn Current and was written by Katherine Unger Baillie. Click here to read this article in its entirety. ____________________________________ Hemophilia is a rare but potentially dangerous disease. People with the condition produce very low levels of clotting factor, the proteins in blood that stop bleeding and help begin the […]